For the Inventor, By the Inventor

Enter assignee name

Hafnarfjördr, Iceland

Actavis Group Ptc Ehf

USPTO Granted Patents = 13

EPO Patents = 3

Trademarks = 1

Forward Citations = 50

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Nitin Sharadchandra Pradhan (11 out of 11 patents)

Jon Valgeirsson (6 out of 6 patents)

Girish Dixit (5 out of 5 patents)

4. Mayur Devjibhai Khunt (4 out of 4 patents)

5. Krishnadatt Sharma (4 out of 4 patents)

6. Sandipan Prabhurao Bondge (3 out of 3 patents)

7. Vikas Daulatrao Ahirao (3 out of 3 patents)

8. Kundan Singh Shekhawat (3 out of 3 patents)

9. Anil Shahaji Khile (2 out of 2 patents)

10. Jayesh Laljibhai Patel (2 out of 2 patents)

11. Richard Anthony Flynn (1 out of 1 patent)

12. Rahul Surana (1 out of 8 patents)

13. Anil Chhettry (1 out of 8 patents)

14. David Farrington (1 out of 1 patent)

15. Ritesh Sanghvi (1 out of 5 patents)

13 patents: Sort by Forward Citations

1. 10441536 - Micronized colistimethane sodium pharmaceutical compositions (2019-10-15),

2. 9512060 - Solid state forms of tapentadol salts (2016-12-06),

3. 9006443 - Process for preparing quinoline-3-carboxamide derivatives (2015-04-14),

4. 8981154 - Solid state forms of tapentadol salts (2015-03-17),

5. 8859769 - Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine (2014-10-14),

6. 8552194 - Process for preparing quinoline-3-carboxamide derivatives (2013-10-08),

7. 8354428 - Solid state forms of laquinimod and its sodium salt (2013-01-15),

8. 8314235 - Process for preparing varenicline, varenicline intermediates, pharmaceutically acceptable salts thereof (2012-11-20),

9. 8288592 - Solid state forms of tapentadol salts (2012-10-16),

10. 8101769 - Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide (2012-01-24),

11. 8101597 - Quetiapine salts and their polymorphs (2012-01-24),

12. 8071767 - Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one hydrochloride (2011-12-06),

13. 7947699 - Anhydrous amorphous imatinib mesylate (2011-05-24),

Actavis Group PTC ehf is a global pharmaceutical company that specializes in the development, manufacturing, and distribution of generic, brand, and over-the-counter (OTC) drugs. With a diverse portfolio of products, Actavis aims to improve access to affordable medications for patients worldwide. The company focuses on providing high-quality, safe, and effective pharmaceutical solutions to healthcare professionals and consumers. With a commitment to innovation and continuous improvement, Actavis strives to enhance patient outcomes and overall healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#1 in Hafnarfjördr

#6 in Iceland

#43,688 in the World

Hafnarfjördr, Iceland

Actavis Group Ptc Ehf

Forward Citations = 50

25 inventors:

Nitin Sharadchandra Pradhan (11 out of 11 patents)

Jon Valgeirsson (6 out of 6 patents)

Girish Dixit (5 out of 5 patents)

4. Mayur Devjibhai Khunt (4 out of 4 patents)

5. Krishnadatt Sharma (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…